ID: ALA5268505

Max Phase: Preclinical

Molecular Formula: C21H16N2O4

Molecular Weight: 360.37

Associated Items:

Representations

Canonical SMILES:  CCOc1cc(/C=N/N2C(=O)c3cccc4cccc(c34)C2=O)ccc1O

Standard InChI:  InChI=1S/C21H16N2O4/c1-2-27-18-11-13(9-10-17(18)24)12-22-23-20(25)15-7-3-5-14-6-4-8-16(19(14)15)21(23)26/h3-12,24H,2H2,1H3/b22-12+

Standard InChI Key:  BJFBJLFGRHPDPF-WSDLNYQXSA-N

Associated Targets(non-human)

Calf thymus DNA 4845 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 360.37Molecular Weight (Monoisotopic): 360.1110AlogP: 3.57#Rotatable Bonds: 4
Polar Surface Area: 79.20Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.56CX Basic pKa: CX LogP: 3.72CX LogD: 3.71
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.57Np Likeness Score: -0.48

References

1. Tomczyk MD, Walczak KZ..  (2018)  l,8-Naphthalimide based DNA intercalators and anticancer agents. A systematic review from 2007 to 2017.,  159  [PMID:30312931] [10.1016/j.ejmech.2018.09.055]

Source